Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA Hepatitis Update - Pegasys and Copegus

On August 22, 2011, the FDA approved the combination of Pegasys and Copegus for the treatment of chronic hepatitis C virus ( HCV ) infection in pediatric patients 5 through 17 years of age.

REFINE

medications
- - (-) Remove Pegasys filter Pegasys
conditions
- - (-) Remove Infectious Disease filter Infectious Disease
    (-) Remove Sexually Transmitted Disease filter Sexually Transmitted Disease
    Hepatitis (1) Apply Hepatitis filter